Immune responses to Helicobacter pylori, with focus on the relation to gastric cancer development

Group leader: This email address is being protected from spambots. You need JavaScript enabled to view it. (Associate professor/Docent, Ph.D.)

Members: Åsa Lindgren (PhD student), Jenni Adamsson (Research technician), PhD-student to be recruited April 2010.
Master students: Kuntal Worah, Chakradhar Yakkala and Giulia Girolimetti.

Gastric cancer is the second most common cause of cancer death in the world and is an increasing problem in many low- and middle-income areas. sl2A major risk factor of gastric cancer is chronic infection with the bacterium Helicobacter pylori, which is highly prevalent in countries with high incidence of gastric cancer.

In this project we study the gastric immune responses to H. pylori infection, as well as the details of local immune networks in gastric cancer patients, in order to understand the process of gastric cancer development. The overall aim of the project is to find ways that will lower the mortality of stomach cancer, by determining useful immunological biomarkers for early stomach cancer and/or prognostic markers that reveal which H. pylori-infected individuals suffer the greatest risk of developing stomach cancer.

Our studies have shown that chronic H. pylori infection is associated with high numbers of suppressive T cells (regulatory T cells, Treg) in the stomach mucosa, which suppress the T-cell response to H. pylori. Furthermore, even higher numbers of Treg are found in the tumour areas of gastric cancer patients, possibly contributing to tumour-induced immunosuppression in these patients.

We have also demonstrated that NK cells are responding to H. pylori infection, but that both gastric and systemic NK cells from gastric cancer patients are totally refractory to stimulation with bacterial components, possibly mediated by tumour-derived TGF-β and subsequent increased expression of GATA-3 in the NK cells.

In parallel with the suppression of potentially tumour-clearing immune responses, we and others have shown that there is a strong ongoing local innate inflammation. We are now analyzing the details of the proinflammatory and immune regulatory gastric cytokine networks in gastric cancer patients and in patients with precancerous conditions. This is done by systems biology approaches using microarray data.

An important aspect of the project is the collection of patient samples, and we have recently initiated a large collaborative study in Nicaragua (coordinated by L Paszat, Toronto), where gastric cancer is a major problem. This study is expected to run for several years, which will allow the collection of follow-up data and enable the detailed analysis of early gastric cancers.

Important publications:

Lundgren, A., Suri-Payer, E., Enarsson, K., Svennerholm, A. & Lundin, B.S. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71, 1755-62(2003).

Lundgren, A., Strömberg, E., Sjöling, A., Lindholm, C., Enarsson, K., Edebo, A., Johnsson, E., Suri-Payer, E., Larsson, P., Rudin, A., Svennerholm, A. & Lundin, B.S. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 73, 523-31(2005).

Yun, C.H., Lundgren, A., Azem, J., Sjöling, A., Holmgren, J., Svennerholm, A. & Lundin, B.S. Natural killer cells and Helicobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production. Infect Immun 73, 1482-90(2005).

Ellmark, P., Ingvarsson, J., Carlsson, A., Lundin, B.S., Wingren, C. & Borrebaeck, C.A.K. Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics 5, 1638-46(2006).

Enarsson, K., Lundin, B.S., Johnsson, E., Brezicka, T. & Quiding-Järbrink, M. CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur J Immunol 37, 282-91(2007).

Lundin, B.S., Enarsson, K., Kindlund, B., Lundgren, A., Johnsson, E., Quiding-Järbrink, M. & Svennerholm, A. The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10. Clin Immunol 125, 205-13(2007).

Kindlund, B., Sjöling, A., Hansson, M., Edebo, A., Hansson, L., Sjövall, H., Svennerholm, A. & Lundin, B.S. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients. Helicobacter 14, 192-201(2009).

Lindgren, Å., Yun, C.H., Lundgren, A., Sjöling, Å., Öhman, L., Svennerholm, A., Holmgren, J. & Lundin, B.S. CD8- NK cells are greatly enriched in the human gastrointestinal tract and have the capacity to respond to bacteria. J Innate Immun In press, (2010).

Lindgren, Å., Pavlovic, V., Flach, C., Sjöling, Å. & Lundin, B.S. IFN-γ secretion is induced in IL-12 stimulated human NK cells by recognition of Helicobacter pylori or TLR2 ligands. Inn Immunity In press, (2010).